Incyte (Nasdaq:INCY) today announced that data from key programs in its oncology portfolio will be presented in both oral and poster sessions at the 2025 American Society of Hematology (ASH) Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback